COMPAMED 2016

Hall 8a, booth G19.3

Surfix BV presents its advanced nanocoatings for the micro- and nanotechnology market. Our proprietary surface modification technology can be used to locally functionalize complex devices with molecular nanocoatings. Our advanced nanocoatings enable the generation of patterned surfaces with multiple functionalities on various inorganic and polymeric surfaces and even inside microfluidic channels, leading to devices with improved performance. Does this sound interesting to you? Then please visit us and let us show you how your device can benefit from Surfix’s advanced surface modification.

Surfix’s photonic diagnostics platform with lab-level precision

Surfix’s mission is to advance global health by delivering accurate, accessible, and affordable diagnostic solutions for disease detection and management, specifically in underserved Point-of-Care (POC) testing segments.

To achieve this goal, Surfix has developed a photonic diagnostics platform that delivers exceptional sensitivity, accuracy, and a broad dynamic range. This cutting-edge technology enables diagnostics with precision surpassing traditional laboratory standards – a POCT with beyond lab-level precision.

Surfix’s objective is to continuously enhance the platform, ensuring it remains easy to use while offering reliable and sensitive detection of a wide array of biomarkers. By doing so, Surfix is committed to elevating healthcare standards and making advanced diagnostics accessible globally.

General Information

Surfix
IVAM member
Agro Business Park 2
6708PW Wageningen
Netherlands
Number of Employees: 25
Founding Year: 2011

Contact

Dr. L.M.W. Scheres
+31 85 488 1285

Latest news

Cancer diagnostics in transition: COMPAMED Innovation Forum 2025 provides insights into the future
02.04.2025 Cancer diagnostics is at a turning point: new technologies are fundamentally changing how we recognize, understand and treat diseases. This …